3D Tomosynthesis
3D tomosynthesis was approved by the FDA in February 2011. It is a revolutionary technology that combines the advantages of digital mammography with a 3D image of the breasts. 3D tomosynthesis creates multiple images or "slices" of the breast tissue which allows our radiologists to see greater detail and helps reduce the impact of overlapping breast tissue. The process is performed at the same time as a normal mammogram, with no noticeable differences in the experience or exam time for the patient.